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Although epithelial cells are continuously shed of cells from the surface of the intestine, the intestinal epithelium maintains the integrity of the epithelial barrier. A highly dynamic process involving re-organization of tight junction and adherens junction proteins achieves this. This process both ejects the cell from the epithelial monolayer and plugs the gap left after the cell is shed. Inflammatory insults can trigger a disturbance of these barrier functions by increasing rates of cell shedding. Epithelial cell shedding and loss of barrier can be visualized by confocal laser endomicroscopy in humans. A simple grading system of confocal laser endomicroscopic images can stratify Inflammatory Bowel Disease patients in remission into those who will relapse over the subsequent 6 months and those who will not. Here, we review the mechanisms governing maintenance of these barrier functions and the implications of inflammation-induced barrier dysfunction in Inflammatory Bowel Disease.


The intestinal epithelium forms a barrier against the intestinal contents and the wider environment [1], allowing entry of selected molecules for nutrition and programming of the mucosal immune system, but excluding toxins and most microorganisms. The epithelium is constantly renewed by new cells derived from stem cells at the crypt base which migrate upwards to either the villus of the small intestine or crypt mouth of the colon, from where they are shed. The entire intestinal epithelium is renewed every 5 to 7 days, a process which, may have evolved to enable epithelial cells to continually function at maximum metabolic efficiency. ADDIN EN.CITE [2-5] However the shedding of the epithelium presents a major challenge to the intestinal barrier, potentially causing a breach at the sites of cell shedding.[6] As this barrier remains intact in health, mechanisms must have evolved to maintain barrier function at these sites.[7] Loss of barrier function has significant mechanistic implications for disease pathogenesis. ADDIN EN.CITE [8, 9] 
Cell shedding in health
Tight junctions between epithelial cells are a major component of the epithelial barrier and are known to be highly dynamic, opening and closing in response to a number of signaling pathways[ to control the passive absorption of water, ions and other solutes.[10] In order for an epithelial cell to be shed from the intestinal epithelial monolayer, reorganization of the tight junction proteins is required. Early electron microscopy studies suggested that tight junctions might rearrange beneath the shedding cell.[11] Subsequently, it has proven possible to study cell shedding and subcellular redistribution of the tight junction protein zonula occludens protein-1 (ZO-1) in vivo. Using transgenic mice expressing a fusion protein of ZO-1 and monomeric red fluorescent protein (mRFP1), coupled with nuclear staining using Hoechst 33342 or 33258 and Lucifer yellow as an intestinal permeability probe, the dynamics of cell shedding in three dimensions can be visualised. ADDIN EN.CITE [12] The first identifiable event with this imaging system was condensation of ZO-1 at the tight junction, followed by redistribution towards the basal pole of the cell. ZO-1 forms a “funnel” around and beneath the shedding cell which when viewed “en face” appears as a “purse string” structure. This ZO-1 redistribution process is completed in approximately 25 minutes. Actin is also redistributed along with ZO-1 and this can be easily visualised with phalloidin staining (Figure 1). Movement of the cell, as defined by movement of the cell nucleus, does not start until 15 minutes after increased condensation of ZO-1 can be identified at the junction, with loss from the monolayer into the lumen taking approximately 15 minutes. Once shed, a “gap” is left in the monolayer, filled with material including ZO-1, which subsequently shrinks and redistributes back to the tight junction over the following 20 minutes. Thus, whilst completion of cell shedding as characterized by monitoring loss of nuclear staining from the monolayer takes approximately 15 minutes, as defined by redistribution of ZO-1, the process takes 45 minutes.
Although Lucifer Yellow sometimes enters the apical region of the intercellular space adjoining the shedding cell, it is always prevented from reaching the basal pole by the ZO-1 containing material, demonstrating maintenance of barrier integrity during cell shedding.[6]
Initial studies identified small numbers of gaps or discontinuities in the epithelium as defined by the lack of intravital staining of the cell nucleus; the majority of resultant gaps could be clearly associated with shedding cells.[6] Subsequent experiments showed that gaps are more often seen in the en face view than the lateral view. ADDIN EN.CITE [12] It also became clear that the dyes Hoechst 333258 and to a lesser extent Hoechst 33342 do not always stain the nuclei of goblet cells, potentially leading to the mis-identification of some gaps. These difficulties were overcome in later studies using additional probes for tight junction components, including ZO-1, and confining analysis to events in which cell shedding can be unequivocally identified.[7]
In summary, these studies confirmed the Madara “zipper” model of maintenance of barrier function during cell shedding. In this model, which is based on data from electron microscopy studies, it was observed that the cells neighboring the shedding cell extend processes beneath the cell about to be shed. These processes included tight junction elements. As the cell is shed the processes from the neighboring cells come together in a process that was likened by Madara to a “zipper” being drawn up thereby maintaining the epithelial barrier at the shedding site.[11] 
TNF-induced Cell Shedding 
Tumor Necrosis Factor- (TNF), an important inflammatory cytokine, increases cell shedding in mice [13], although the degree of stimulation of cell shedding is highly variable from experiment to experiment. This may partially be explained by the highly variable rates of endogenous cell shedding in the murine intestine. In contrast to the healthy gut, after administration of TNF, barrier function is disturbed by increases in cell shedding and by the simultaneous shedding of two or more cells at certain sites, producing micro-erosions that cannot be sealed by tight junction protein redistribution.[14] 
The redistribution of tight junction proteins has been studied in detail following TNF administration. Although low doses of TNF do induce some structural and functional changes in the tight junctions, high doses (7.5g) are required to reliably induce cell shedding. Studies were undertaken in mRFP1-ZO-1 mice described above, and also in a further transgenic mouse strain in which the tight junction protein, occludin, is conjugated to enhanced green fluorescent protein.[7] The redistribution of ZO-1 was very similar to that seen in the healthy mouse intestine. Similar results were obtained with occludin, though the results were less clear, as expression of occludin is not restricted to the tight junction.[7] Immunohistochemical studies showed that the tight junction proteins claudin-7 and claudin-15 form a funnel around the shedding cell, suggesting that all tight junction proteins may be redistributed during cell shedding. ADDIN EN.CITE [7, 15] Furthermore E-cadherin, a component of the adherens junction, is also redistributed. ADDIN EN.CITE [16]
The very rapid redistribution of transmembrane proteins occludin, claudins and E-cadherin to cover the entire basolateral membranes is remarkable, and suggests that membrane traffic might be involved. This was confirmed with dynasore, an inhibitor of dynamin the GTPase responsible for endocytosis, which trapped cells in a partially extruded position unable to complete shedding. ADDIN EN.CITE [7, 17]
Antibody studies for activated caspase 3 show that during cell shedding, the cell undergoes apoptosis. ADDIN EN.CITE [3, 4] It has long been debated whether apoptosis is a cause or consequence of cell shedding. ADDIN EN.CITE [18, 19] Infusion of the intestine with the pan caspase inhibitor Q-VD-OPH inhibits TNF-induced cell shedding.  Thus in the case of TNF-induced cell shedding, it is clear that TNF first induces apoptosis, which subsequently induces cell shedding as a secondary event. Unfortunately, low rates of endogenous cell shedding make such studies in healthy intestine a considerable technical challenge and have therefore not been described. Interestingly, studies in human small intestine have shown that Acyl-CoA synthetase is differentially expressed along the crypt / villus axis, and that such differential expression may sensitize enterocytes at the villus tip to apoptotic cell death, via the death receptor TRAIL R1.  ADDIN EN.CITE [20] This provides one possible mechanistic explanation for loss of cells at the villus tip.
Actomyosin contraction and redistribution of Actin is also important in initiating cell shedding. Cytochalasin D, an inhibitor of actin polymerization, reduces cell shedding by 60%.[21] Myosin IIC, but not IIA or IIB, is redistributed around the shedding cell and the myosin II motor inhibitor blebbistatin also strongly inhibits shedding. ADDIN EN.CITE [22]  Involvement of actomyosin contraction suggests that the actin regulatory proteins Rho-associated Kinase (ROCK) and Myosin Light Chain Kinase (MLCK) also participate. ADDIN EN.CITE [4, 23-25] Consistent with this idea, increased phosphorylation of myosin light chains was observed on the lateral walls adjacent to the shedding cell whilst the rho kinase inhibitor Y27632 and MLCK-/- mice significantly reduced cell shedding. ADDIN EN.CITE [26] Microtubule polymerization is also important in the early stages of cell shedding as the microtubule depolymerising agent colcemid inhibits the early stages of cell shedding. ADDIN EN.CITE [5, 7] 
Cell shedding following apoptotic stimuli
Studies using in vitro monolayer culture models of cell extrusion provide further insight into the absolute requirement for tight regulation of these processes in vivo. Using MDCK II and 16 HBE-14o cell lines, it was shown that epithelia can trigger extrusion following intrinsic or extrinsic apoptotic stimuli, and that these extrusion pathways are partially dependent upon mitochondrial outer membrane permeabilisation (MOMP) and caspase activation. Importantly, knockdown of caspases results in cells dying by necrosis, and subsequently being removed by passive cell movement.[19]  Thus caspase activation appears to be a conserved step in the apoptotic pathway and not simply a result of TNF induced epithelial shedding. Caspase activation might in turn control tight junction and adherens junction re-organisation to facilitate maintenance of barrier function, although in vivo studies suggest that ZO-1 re-distribution provides the earliest indicator of cell shedding. ADDIN EN.CITE [12] Furthermore, synthesis of sphingosine-1-phosphate is important for cell shedding, as inhibition of sphingosine kinase inhibits cell shedding in zebrafish. ADDIN EN.CITE [27] Future studies should determine whether the re-distribution of ZO-1 precedes, or occurs co-incident with, mitochondrial dysfunction and / or caspase activation. 
Further recent studies using zebrafish have also provided insight into the role of the tumour suppressor gene APC, a member of Wnt family of signaling molecules. APC localises near sites of actomyosin contraction during apical and basal extrusion, and in association with the microtubules, is critical for determining the direction of cell extrusion from the monolayer.[28] In these studies the stimulis for cell shedding is not known but part of Zebra fish development. The authors argue that inward shedding into the intestinal wall may be a mechanism that APC mutation encourages cancer growth and metastasis in colon cancer. 
Together, these studies suggest a tentative ordering of events in which cell shedding is initiated by apoptosis with contributions from MLCK, myosin ATPase, sphingosine kinase activity and microtubule events. This may be coincident with, or followed by, redistribution of microtubules, tight junction and adherences junction proteins along the lateral membranes into a funnel like structure around the shedding cell. Completion and resolution of the shedding requires ROCK, MLCK and dynamin. An important caveat is that none of the inhibitors completely prevented cell shedding suggesting the existence of alternative escape pathways.[7]

Cell shedding in Humans
The development of an endoscopic device incorporating a confocal microscope has enabled studies of cell shedding to be undertaken in humans and produce images similar to those from paraffin sections of fixed intestinal biopsies stained with Haematoxylin and Eosin. ADDIN EN.CITE [3]. Initial studies were undertaken using acriflavine as the fluorescent probe.[29] Acriflavine promiscuously labels all cellular elements, but fluorescence from the nucleus is more efficient than from the rest of the cell, making it an excellent tool for cell shedding studies. Indeed, epithelial gaps, probably resulting from cell shedding, could be easily identified. As discussed, epithelial gaps can be difficult to definitively distinguish from goblet cells. However, at confocal endomicroscopy, it was possible to show that goblet cells have a specific appearance when the focal plane is positioned at the apical surface of the cell. Such analysis generates a composite image showing the mouth of the goblet cell, the surrounding cytoplasm and the endogenous mucin, thus distinguishing goblet cells from epithelial gaps. A further distinguishing feature is that the acriflavine efficiently labels the nuclei of goblet cells and does not have the poor labeling efficiency of the Hoechst dyes. To gain further evidence that epithelial gaps were not mis-identified goblet cells, we imaged in the intestine of mice with an intestine specific deletion of the transcription factor Math1 (Math1intestine). ADDIN EN.CITE [30] These mice lack goblet cells in the distal small intestine. Using a hand held confocal endomicroscope (Optiscan) and electron microscopy, presence of epithelial gaps was shown in these mice along with examples of shedding cells creating epithelial gaps. 
Recently, studies have been undertaken with fluorescein as a fluorescence probe.[14] Unlike acriflavine, which is sprayed onto the epithelial surface via the endoscope, fluorescein is administered intravenously. Fluorescein does not provide the subcellular resolution of acriflavine, but is able to image epithelial cells during the process of cell shedding and can be used as a probe for barrier defects. Although delivered intravenously, a little dye leaks out of submucosal capillaries in the intestine and will label epithelial cells. Some dye will also track between the epithelial cells in the lateral intercellular spaces. Fluorescein cannot traverse the tight junction at the apical border of the epithelial cell and only leaks into the lumen at sites of barrier loss. This use of fluorescein with confocal endomicroscopy is the only method to visualize sites of epithelial barrier loss in a clinical setting. Alternative methods of assessing intestinal barrier function include absorption of small molecular weight saccharides or Cr-EDTA and measurement of their appearance in the urine.[31] These methods have proved useful in providing an integrated measurement of barrier function along a long segment of gut, but provide no information of the precise site of barrier loss.[32] Electrophysiological methods can give very precise functional information, but again do not provide visual information. ADDIN EN.CITE [33-35] 
In the healthy gut, the fluorescein signal from the lumen should be absent or of lower intensity than the adjacent epithelium. When the barrier is impaired, such as sites of microerosions, fluorescein will rapidly enter the lumen, making it intensely fluorescent. Sometimes, “plumes” of fluorescein can be seen flooding out of the epithelium, suggesting there is pressure within the villus forcing the fluorescein out (Figure 2). 
There is a potential difficulty with the fluorescein method for detecting barrier defects, since it can only visualize efflux from the villus interior, across the epithelium and into the lumen. ADDIN EN.CITE [36-38] Most disease pathogenesis scenarios involve influx of material from the intestinal lumen into the lamina propria; in other words in the opposite direction to fluorescein efflux. This issue was addressed in mouse experiments in which Alexa-fluor 647 conjugated dextran was administered intravenously to visualise the villus vasculature and potential efflux from the intestine into the lumen. Simultaneously, FITC-conjugated dextrans were applied to the luminal surface in a solution of 300mOsm/l, to assess influx across the intestinal barrier. When the luminal osmolarity was isotonic relative to plasma, the direction of flow was outward into the lumen in the majority of cases (76%) of cell shedding, with a significant minority showing inward flow (18%) and some (6%) showing bi-directional flow (interpreted as free diffusion in both directions). Reducing luminal osmolarity to 246 MOsm/l increased both inward and bidirectional flow at these leaking sites, showing that direction of flow is is critically dependant upon luminal osmolarity. Thus, the outward flow seen with fluorescein at confocal endomicroscopy of humans seems a reasonable surrogate for areas of inward flow. Although classically the intestinal lumen is considered to isotonic, there are likely to be areas of incomplete mixing, resulting in a wide range of osmolarities within the intestinal lumen. Thus, in individuals with barrier loss, the degree of influx of undesirable luminal molecules will vary both with position in the gut and also with time. 

Barrier loss and cell shedding in Inflammatory Bowel Disease (IBD)
It remains unknown whether barrier dysfunction is a cause or effect of IBD. Using a mouse model which enables targeted disruption of intestinal epithelial tight junctions via constitutive activation of MLCK, increases in para-cellular permeability of up to 65% were shown to pre-dispose and contribute to the development of subclinical immune activation and hallmarks of IBD. These included a 40% increase in lamina propria CD4+ lymphocytes and re-distribution of CD11c+ cells (possibly dendritic cells) along with mild increases in IFN- γ and TNF. ADDIN EN.CITE [39] Importantly, mice showed a worse clinical outcome in an adoptive transfer model of colitis. Further studies demonstrated that constitutive activation of MLCK produced increases in mucosal IL-13, resulting in increases in levels of claudin-2 and consequently, an increase in the number of small pores.[40] Thus, the ability of the tight junction to maintain epithelial barrier integrity is vital to health.

Defects in intestinal barrier function have been reported previously in IBD, [41] using absorption of polysaccharides to measure barrier function. It was therefore of interest to determine if defects in intestinal barrier could be detected in patients with Crohn’s Disease or Ulcerative colitis using the confocal endomicroscopy/fluourescein technique described above. A retrospective study of IBD patients was undertaken which demonstrated substantial increases in epithelial gaps, micro-erosions and fluorescein leakage in these patients compared to age matched controls. Results were used to create a three tier grading system, the Watson score, which reflected severity of epithelial shedding and barrier loss. A Watson grade of I is normal physiological cell shedding, defined as single cells being shed. In preliminary versions of the grade, we found that the number of cells being shed did not predict subsequent relapse, providing there was no fluorescein leakage or micro-erosions created by multiple cells being shed from a single site. Thus the number of shedding cells being lost is not part of Watson grade I. Evidence of loss of barrier function when fluorescein leaks into the lumen is designated Watson grade II (functional defect). Micro-erosions caused by multiple epithelial cells being shed from a single site revealing the lamina propria to the lumen is designated Watson grade III (structural defect).[14]

The Watson grading system was used to evaluate 58 patients with IBD using images from the terminal ileum (47 Ulcerative colitis, 11 with Crohns disease). At the time of endomicroscopy these patients were in clinical remission and had normal macroscopic appearances of the terminal ileum. 24 patients suffered a flare of their disease within 12 months after the confocal laser endomicroscopic (CLE) examination. Kaplan Meier analysis was undertaken of relapse for the 12-month period after CLE, following stratification by their Watson grade. Patients who subsequently had a flare of their disease had significantly more fluorescein leakage and micro-erosions; thus a higher Watson grade, than patients who did not suffer a flare p <0.001. The sensitivity, specificity and accuracy for the Watson scores II/III to predict flares were 62.5% [CI 95%: 40.8-80.4], 91.2% [CI 95%:75.2-97.7] and 79% [CI 95%: 57.7-95.5], respectively. Additional studies which demonstrated that patients with IBD show a greater gap density distribution than control patients (median gap density 61 per 1000 cells versus 18 per 1000 cells; p< 0.001) support this work [42]

Overall, it appears that CLE will prove useful in predicting the likelihood of inflammatory relapse and may therefore be a useful new tool for management of targeting biological and immunosuppressive therapy to IBD patients at risk of relapse. 

Concluding remarks and future directions
Whilst recent advances have provided valuable insights into many aspects of cell shedding and barrier function in inflammation and infection, significant questions remain. It is interesting that rates of cell shedding increase in response to inflammatory stimuli, but this raises the critical question of how such increases in rates of cell loss are balanced by proliferation in cells within the transit amplifying region and / or stem cell compartment, and how signals might be propagated from the sites of shedding, to the crypt. It seems likely that epithelial renewal is highly dynamic and is regulated according to microbial load, inflammatory stimuli, or other external factors. Recent studies in Drosophila suggested a molecular link between the disturbance of gut microbiota, the immune response and proliferation of intestinal stem cells. ADDIN EN.CITE [43] Delineating the mechanisms governing such intracellular messaging in mammals will accelerate our understanding of many chronic inflammatory diseases such as IBD. 

Observations in mRFP-1 Z0-1 transgenic mice that 15% of cells neighboring the shedding cell also begin the extrusion process some 5-10 minutes later raise further questions about the potential methods of cell to cell communication between shedding cells and their local environment. ADDIN EN.CITE [12]  It is interesting that whilst this latter study suggests that neighbouring cells do not produce any local force to facilitate extrusion of shedding cells, conflicting in vitro studies suggest a significant involvement of neighbours in this process.[44] It nevertheless seems likely that some cell-cell communication between extruding cells and their neighbours does take place. Understanding these methods of communication (via GAP junctions, cytokines or otherwise) should provide new perspectives on the process of cell shedding in health and disease. 

Other interesting observations in zebrafish that APC, a gene commonly associated with colon cancer, is implicated in a cell’s decision of whether to extrude basally or apically, raise the possibility that mutations of the APC gene, as frequently observed in colon cancer, may lead to increased rates of basal extrusion, leading to metastasis.[44] Curiously, studies in jejuna of mice have only described apical shedding with no description of such events occurring basally into the lamina propria of the villus. Ischaemic reperfusion models in human small intestine have demonstrated a surprising ability for jejunal tissue to rapidly clear apoptotic cells from the epithelium to avoid an inflammatory response caused by unresolved necrotic cells.[45]  These studies indicate the importance of rapid apical extrusion during periods of insult / injury. Defective apical extrusion may thus lead to basally oriented extrusion and / or phagocytosis of potentially necrotic cells. It is tempting to speculate that higher incidences of colon versus small intestinal cancer may be partially regulated by mutations in the APC gene and the subsequent failure of colonic apical extrusion.
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1.	Phalloidin staining of actin redistribution around a shedding cell (thin arrow). The nucleus is the process of being extruded is shown (thick arrow. ZO-1  (Adapted from [7]) 

2.	Efflux of fluorescein (black arrow) at a site of local barrier loss. Image from confocal endomicroscopy of the terminal ileum of a patient with Crohn’s disease. Efflux of fluorescein only occurs at a single cell position, probably at a site of cell shedding, where sealing of the resulting gap has failed. The tight junction prevents efflux of fluorescein where the epithelium is intact (white arrow). (Adapted from [14]).




